Boost for chronic respiratory care worth $11.78m

3 minute read


A new national collaboration will target earlier diagnosis, integrated care, and updated clinical guidance, with health equity central to its remit.


Lung Foundation Australia has secured $11.78 million in federal government funding to overhaul the prevention, detection and management of chronic respiratory disease, including delivering a major update to the COPD-X guidelines. 

The funding will support the Australian Chronic Respiratory Alliance (ACRA), a consortium of 10 national health and advocacy organisations, through to June 2030. 

Led by Lung Foundation Australia, the Australian Chronic Respiratory Alliance brings together the National Heart Foundation of Australia, the National Stroke Foundation, the Sleep Health Foundation, Scleroderma Australia, and Eczema Support Australia. 

Other consortium members include Jean Hailes for Women’s Health, the Safer Air Project, the Federation of Ethnic Communities’ Councils of Australia, and the National Rural Health Alliance, bringing expertise in chronic disease management, consumer advocacy, and health equity to support more coordinated respiratory care. 

The funding, delivered under the federal government’s Chronic Conditions Prevention and Integrated Care Program, will support the development of clinical guidance, education for health professionals, and practical resources for patients. 

A key focus will be improving care for patients with multiple chronic conditions, with an estimated 88% of Australians aged 45 years and over with chronic obstructive pulmonary disease (COPD) living with at least one other chronic condition in 2022. 

The investment comes amid a significant burden of undiagnosed respiratory disease, with an estimated one in 13 Australians aged over 40 years living with COPD, almost half of whom may be unaware they have the condition. 

According to the Australian Institute of Health and Welfare, potentially avoidable COPD hospitalisations accounted for an estimated $797 million in expenditure in 2023-24, the third highest amount for any chronic condition. 

The funding will also enable Lung Foundation Australia to deliver COPD-X 3.0, a key commitment under its 2026-30 corporate plan. 

Lung Foundation Australia CEO Mark Brooke said the investment would support a more coordinated national approach to respiratory healthcare. 

“Through ACRA, we can strengthen clinical guidance and education, provide practical resources for consumers and help ensure evidence informs care,” he said. 

“We now move into implementation, working together and drawing on the strengths each organisation brings.” 

The alliance will draw on expertise in cardiovascular disease, sleep health, atopic disease, women’s health, scleroderma, air quality, and health equity. 

Eczema Support Australia managing director Melanie Funk said the collaboration presented an opportunity to improve integrated care for patients with overlapping allergic and respiratory conditions. 

“Eczema is often the first sign of atopic disease, and many people with eczema also live with asthma and allergies,” she said. 

“Through ACRA, Eczema Support Australia will bring the lived experience of people with atopic conditions to national guidance and consumer resources, so care is joined up rather than managed one condition at a time.” 

Jean Hailes for Women’s Health CEO Dr Sarah White welcomed the alliance’s commitment to addressing sex and gender differences in respiratory disease. 

“The reality is that respiratory diseases affect women and men differently,” she said. 

“Undertaking a program of work that examines and addresses these differences will improve respiratory disease care for everyone.” 

The alliance will also seek to address disparities in respiratory health outcomes among rural and remote populations and improve access to culturally responsive health information for multicultural communities. 

National Rural Health Alliance chief executive Susi Tegen said the burden of COPD increased with geographical remoteness. 

Federal health minister Mark Butler said earlier diagnosis and better coordinated care could help reduce avoidable hospitalisations. 

“This latest investment will help strengthen lung health across Australia and improve outcomes for people living with chronic respiratory disease,” he said. 

End of content

No more pages to load

Log In Register ×